NewsMeter
37% is the five-year survival rate once prostate cancer has spread to distant parts of the body, per the American Cancer Society.
Former President Joe Biden, 83, is now in that clinical category: his son Hunter Biden told BBC Newsnight that the disease has metastasized into his bones, describing the condition as "very painful" and "very debilitating in many respects." Biden had completed a course of radiation at Penn Medicine Radiation Oncology in Philadelphia in October 2025 and was on hormone therapy, treatments his office characterized at the time of his May 2025 diagnosis as allowing "effective management." The incidence backdrop The American Cancer Society projects 333,830 new U.S.
prostate cancer cases in 2026, against an expected 36,320 deaths. One in eight men will receive the diagnosis at some point in their lives.
That caseload is growing: overall incidence rose roughly 3% per year from 2014 through 2021. Advanced-stage cases climbed faster, at approximately 5% annually over the same period.
Keep reading